Chargement en cours...
Chronic myeloid leukemia: sequencing of TKI therapies
Multiple tyrosine kinase inhibitors (TKIs) are available for managing patients with chronic myeloid leukemia. Although most patients have a favorable outcome with their initial therapy, whether imatinib or a second-generation TKI was used, some will require subsequent use of one or more different TK...
Enregistré dans:
| Publié dans: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Hematology
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6142480/ https://ncbi.nlm.nih.gov/pubmed/27913476 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|